A review on Bhallatak in Management of lifestyle disorder Prameha (diabetes mellitus)

International Journal of Research in Indian Medicine

Article pdf download
Publication Certificate

Keywords

Bhallatak, semicarpus anacardium, Prameha, Diabetes mellitus, lifestyle diseases, Anti hyperglycemic agents, Insulin

How to Cite

Shende, H. (2019). A review on Bhallatak in Management of lifestyle disorder Prameha (diabetes mellitus). Ayurline: IJ-RIM, 3(03). Retrieved from http://www.ayurline.in/index.php/ayurline/article/view/229

Abstract

Lifestyle diseases are diseases linked with the way people live their life. This is commonly caused by lack of physical activity, unhealthy eating, lack of organic (food-fruits-vegetables), irregular daily routine i.e. (sleep, irregular meals, toilet) etc. Alcohol intake, drug consumption and smoking are also responsible factors. Diseases that impact on our lifestyle are heart disease, stroke, obesity and type II diabetes. Diabetes mellitus is a metabolic disorder characterized by hyperglycemia due to defect in insulin secretion, action, or both. Liver plays an important role in the glucose homeostasis through glycolysis, glycogenesis, and gluconeogenesis.

Semicarpus anacardium (‘Bhallatak’) has been used in various traditional system of medicines for various ailments since ancient times. Its nut contains a variety of biologically active compounds such as bioflavonoid, phenolic compounds, bhilawanols, minerals, vitamins and amino acids, which show various medicinal properties. The fruit and nut extract shows various activities like hypoglycemic anti-artherogenic, anti-inflammatory, antioxidant, antimicrobial, anti-reproductive, CNS stimulant, anti-carcinogenic and hair growth promoter. Research study revealed, the ethanolic extract of SA (100 mg/kg) reduced the blood glucose of normal rats. Bhallatak was able to restore the altered activities of the enzymes involved in carbohydrate metabolism and energy production.

Article pdf download
Publication Certificate

References

1. "About diabetes". World Health Organization. Archived from the original on 31 March 2014. Retrieved 4 April 2014
2.Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds.). Williams textbook of endocrinology (12th ed.). Philadelphia: Elsevier/Saunders. pp. 1371–1435. ISBN 978-1-4377-0324-5.
3.Visscher TL, Snijder MB, Seidell JC (2009). "Epidemiology: Definition and Classification of Obesity". In Kopelman PG, Caterson ID, Dietz WH. Clinical Obesity in Adults and Children (3rd ed.). Wiley-Blackwell. p. 7. ISBN 978-1-4443-0763-4
4.Shoback DG, Gardner D, eds. (2011). "Chapter 17". Greenspan's basic & clinical endocrinology (9th ed.). New York: McGraw-Hill Medical. ISBN 978-0-07-162243-1.
5. "Diabetes Fact sheet N°312". WHO. October 2013. Archived from the original on 26 August 2013. Retrieved 25 March 2014.
6. Fauci et 61al,Harrisons Internal Medicine , Chapter 338, Page No. 2271-75, 17th Edition,Mc Graw Hill medical,2008.9
7. Brown JB, Nichols GA, Glauber HS, Bakst A. Ten-year follow-up of antidiabetic drug
use, nonadherence, and mortality in a defined population with type 2 diabetes mellitus.
Clin Ther. 1999; 21(6):1045-1057.
8. Rippe RS, Irwin JM, eds. (2010). Manual of intensive care medicine (5th ed.). Wolters Kluwer Health/Lippincott Williams & Wilkins. p. 549. ISBN 9780781799928.
9. Kirtikar KR, Basu BD. Indian medicinal plants. Vol. 3. Dehradun, India: International Booksellers and Publishers; 1975. pg. 667.
10. Bhitre MJ, Patil S, Kataria M, Anwikar S, Kadri H. Antiinflammatory activity of the Bhallatak.
11. Singh M.P. and Himadri Panda, Medicinal herbs with their formulations, Vol.II, Daya Publication House, Delhi, 2005. pg758.)
12. Database on medicinal plant used in ayurveda & siddha Vol 5, CCRAS Dept. of Ayush,Ministry of health and family welfare GOI. 2008, PP 9-14)
12a. Mishra Brahmashankar,Bhawprakash Part I, Dhatwadi Varga/verce191, 206, Reprint edition tion 2013, Chowkhamba Sanskrit Bhawan Varanasi,page 629,634.
12b. Dr. Indradev Tripathi. Raj Nighantu. 5th edition. Chaukhamba krishnadas academy Varanasi.2010 pg.353
12c. Ayurvedodharaka Shaligram Vaishya. Shaligram Nighantu. Khemraj Shrikrishnadas, Shri Venkateshwar press, Mumbai.
12d. Acharya Priyawat sharma, Dr. Guruprasad sharma. Kaiyadeva Nighantu, 1st edition. Chaukhamba Orientalia, Varanasi.
13.Shukla V, Tripathi RD, Charak Samhita of Agnivesha,Reprint edi-2015,Choukhamba Sanskrit pratishthan Delhi,Chikitsasthan1/2, pp.13-15, Rasayan adhyay, prankamiya pad; pg21-24
14. Sharma Anant ram,Sushrut Samhita of Sushruta,Chaukhamba surbharati prakashan, 1st edition2013,Chikitsasthan 6/17,9/7 pp.231,251; kalpsthan 1/69-71.pg 513.
15. Tripathi Brahmanand, Ashtang Hridaya of Vagbhat, Choukhamba Sanskrit pratishthan Delhi, Reprint edition 2011;Chikitsasthan 1/154 .pg.574.
16.Sadanand sharma,Rastarangini,motilal banarasidas Delhi ,11th edition,1979; pg.735
17. Pilay VV, Modern Medical Toxicology,4th edition 2013,Jaypee brothers medical publishers, pg. 124-125
18. Pillay VV, Modern Medical Toxicology,4th edition 2013,Jaypee brothers medical publishers, pg. 124-125

I  declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein. All agreed to the terms and conditions, Privacy Policy, which is declared on Journal Website http://www.ayurline.in and online filled (uploaded) form